Activity of Afatinib in Uncommon Epidermal Growth Factor...

Annals of Oncology 2012 / 09 Vol. 23

Activity of Afatinib in Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations in Lux-Lung 3, A Phase III Trial of Afatinib or Cisplatin/Pemetrexed in EGFR Mutation-Positive Lung Cancer

Yang, J.C., Schuler, M., Yamamoto, N., O'Byrne, K.J., Hirsh, V., Mok, T.S.K., Massey, D., Zazulina, V., Shahidi, M., Sequist, L.V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33845-x
Date:
September, 2012
File:
PDF, 80 KB
2012
Conversion to is in progress
Conversion to is failed